NPC

9 registered clinical trials studyying NPC — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Pembrolizumab + MRGOO3 as Neoadjuvant in NPC NCT07267338	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2
Not Yet Recruiting	A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Cur NCT06719479	SUNHO（China）BioPharmaceutical CO., Ltd.	Phase 2 / Phase 3
Completed	IBI310 in Combination With Siltilimab in Subjects With Anti-PD-1/PD-L1 Resistance R/M NPC NCT04945421	Innovent Biologics (Suzhou) Co. Ltd.	Phase 1
Active Not Recruiting	NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer NCT03734809	Chinese University of Hong Kong	Phase 2
Recruiting	Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma NCT03919552	Nanfang Hospital, Southern Medical University	Phase 3
Completed	IMRT vs 2DRT for NPC Patients NCT03352778	Chinese University of Hong Kong	—
Unknown	Phase IIa Dose-Expansion and Biomarker Study of OPB-111077 NCT03158324	National University Hospital, Singapore	Phase 2
Completed	Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients NCT01744587	National Health Research Institutes, Taiwan	N/A
Completed	Plasma EBV DNA Monitoring in Post-treatment NPC Patients NCT03973723	Taichung Veterans General Hospital	—